Abstract
Thioredoxin reductase plays a critical role in the regulation of cancer cell apoptosis, making it an attractive target for the design of new anticancer drugs. Several classes of compounds have been considered as potential antitumor or chemopreventive agents; most of them apparently interact with thioredoxin reductases C-terminal redox center.
Keywords: Thioredoxin reductase, redox system, antitumour agents, TrxR substrates, alkylating agents, reversible TrxR inhibitor, motexafin gadolinium, ethaselen, Targeting Thioredoxin Reductase, Chemopreventive Compounds, redox homeostasis, 1,2-[bis(1,2-benzisoselenazolone-3, NADPH, TrxR1 mRNA, glutathione reductase, selenenyl-sulfide, FAD domain, Cys mutant enzyme, nucleophilic, platinum compounds, efficaciousness, Motexafin Gadolinium (MGd), Aurothioglucosea, Selenodiglutathione (GS-Se-SG), peroxidase-mimicking, Anticancer Alkylating Agents, aziridinyl quinone diaziquone, Ebselene, cytotoxicity, aurothioglucose, antiproliferative agent, Curcumin, α,β-unsaturated ketone structure, carcinogenesis, mercaptoimidazole moiety, methylseleninate, nasopharyngeal (KB), TrxR inhibition, GSH, ROS
Medicinal Chemistry
Title: Targeting Thioredoxin Reductase: Anticancer Agents and Chemopreventive Compounds
Volume: 6 Issue: 5
Author(s): H. H. Zeng and L. H. Wang
Affiliation:
Keywords: Thioredoxin reductase, redox system, antitumour agents, TrxR substrates, alkylating agents, reversible TrxR inhibitor, motexafin gadolinium, ethaselen, Targeting Thioredoxin Reductase, Chemopreventive Compounds, redox homeostasis, 1,2-[bis(1,2-benzisoselenazolone-3, NADPH, TrxR1 mRNA, glutathione reductase, selenenyl-sulfide, FAD domain, Cys mutant enzyme, nucleophilic, platinum compounds, efficaciousness, Motexafin Gadolinium (MGd), Aurothioglucosea, Selenodiglutathione (GS-Se-SG), peroxidase-mimicking, Anticancer Alkylating Agents, aziridinyl quinone diaziquone, Ebselene, cytotoxicity, aurothioglucose, antiproliferative agent, Curcumin, α,β-unsaturated ketone structure, carcinogenesis, mercaptoimidazole moiety, methylseleninate, nasopharyngeal (KB), TrxR inhibition, GSH, ROS
Abstract: Thioredoxin reductase plays a critical role in the regulation of cancer cell apoptosis, making it an attractive target for the design of new anticancer drugs. Several classes of compounds have been considered as potential antitumor or chemopreventive agents; most of them apparently interact with thioredoxin reductases C-terminal redox center.
Export Options
About this article
Cite this article as:
H. Zeng H. and H. Wang L., Targeting Thioredoxin Reductase: Anticancer Agents and Chemopreventive Compounds, Medicinal Chemistry 2010; 6 (5) . https://dx.doi.org/10.2174/157340610793358864
DOI https://dx.doi.org/10.2174/157340610793358864 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Carbohydrates in Computational and Medicinal Chemistry
Carbohydrates are the most essential organic molecules and are involved in the maintenance of various physiological and metabolic processes in living organisms. Carbohydrate-based compounds have come to the attention of researchers because of their significant contributions to biological functions, such as cell development and cell proliferation, connections between several cells, ...read more
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins
Recent Patents on Anti-Cancer Drug Discovery Patent Selection
Recent Patents on Nanotechnology Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non- Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management
Current Drug Safety Therapeutic Vaccines Explored in Patients with Non-Small Cell Lung Cancer
Anti-Cancer Agents in Medicinal Chemistry Drug Carriers in Pharmaceutical Design: Promises and Progress
Current Pharmaceutical Design Unique Medicinal Properties of Withania somnifera: Phytochemical Constituents and Protein Component
Current Pharmaceutical Design Chronic Exposure to Low-Level Cadmium in Diabetes: Role of Oxidative Stress and Comparison with Polychlorinated Biphenyls
Current Drug Targets Radiological Screening Programs for Women at High Risk of Developing Breast Cancer
Current Women`s Health Reviews Nebulizer Therapy in Pulmonology: Review of the Literature
Current Respiratory Medicine Reviews Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems
Current Medicinal Chemistry From Laptop to Benchtop to Bedside: Structure-based Drug Design on Protein Targets
Current Pharmaceutical Design Antagonists of IAP Proteins: Novel Anti-Tumor Agents
Current Medicinal Chemistry Heat Shock Protein 90 Inhibitors as Broad Spectrum Anti-Infectives
Current Pharmaceutical Design Discovery of Small Molecule c-Met Inhibitors: Evolution and Profiles of Clinical Candidates
Anti-Cancer Agents in Medicinal Chemistry Epigenetic Regulation of Genes Encoding Drug-Metabolizing Enzymes and Transporters; DNA Methylation and Other Mechanisms
Current Drug Metabolism Role of Iodine, Selenium and Other Micronutrients in Thyroid Function and Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets Pharmacometrics of Stilbenes: Seguing Towards the Clinic
Current Clinical Pharmacology γ δ T Cell Modulation in Anticancer Treatment
Current Cancer Drug Targets Sugar-Borate Esters – Potential Chemical Agents in Prostate Cancer Chemoprevention
Anti-Cancer Agents in Medicinal Chemistry TGF-β Receptor Signaling Pathways in Angiogenesis; Emerging Targets for Anti-Angiogenesis Therapy
Current Pharmaceutical Biotechnology